Impact of GPBAR1 Modulation on Immune Cell Responses in TNBS-Induced Colitis Models
This study examines the effects of GPBAR1 modulation on various immune cells in the context of TNBS-induced colitis. Specifically, we evaluate the response of CD3+ and CD14+ cells under the influence of Ciprofloxacin and GPBAR1 activation. Results show significant differences in cell populations, suggesting that GPBAR1 plays a crucial role in regulating immune responses during inflammation. Our findings could have implications for therapeutic approaches targeting GPBAR1 in gastrointestinal diseases.
Impact of GPBAR1 Modulation on Immune Cell Responses in TNBS-Induced Colitis Models
E N D
Presentation Transcript
2°ab alone GPBAR1+ LPMC Control TNBS + vehicle TNBS + Ciprofloxacin A B E Control TNBS TNBS + Ciprofloxacin C %CD3/GPBAR1+ cells 2,16 ± 0,06 %CD3/GPBAR1+ cells 3,59 ± 0,11 %CD3/GPBAR1+ cells 3,31 ± 0,18 CD3+ cells D %CD14/GPBAR1+ cells 89 ± 3,2 %CD14/GPBAR1+ cells 92 ± 4.5 %CD14/GPBAR1+ cells 84 ± 5.5 CD14+ cells GPBAR1+ cells Figure 5